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Abstract
Background
One in seven infant deaths are caused by bacterial, viral, or fungal infections. Systemic
diseases, such as bacterial pneumonia, cardiovascular disease, and acute otitis media have a
potential etiology in the oropharynx (Williams, Embleton, Bythell, Ward Platt, & Berrington,
2013). At birth, the blue-bulb syringe (BBS) is commonly used to remove oral and nasal
secretions from the neonate; without effective cleaning, the BBS becomes a potential reservoir in
the chain of infection. Thus, the BBS may be contributing to many childhood diseases, leading to
increased healthcare costs and long-term growth and developmental issues. The aim of this
descriptive pilot study is to test specimens harvested from BBSs to determine if bacterial
microbes migrated into the BBS following standard suctioning protocols in three settings: 1)
vaginal births, 2) cesarean births, and 3) a mother/baby unit upon discharge of patient.
Method
During two weeks in August 2014, at a large urban teaching hospital, 175 BBSs were
collected and transported to a microbiology lab. Once inspected and labeled, all BBSs were
stored at 4°C until processed. During the proceeding months, an interprofessional team of
undergraduate nursing and biology students extracted specimens from the BBSs to determine the
presence of bacterial growth within each of the specified categories.
Results
Viable bacterial colonies were found in each of the three settings where BBSs were
examined. Among all BBSs collected, there was a 42% growth rate. Forty-four percent of BBSs
collected at time of discharge, and 41% collected during the birthing process contained bacterial
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colonies. When comparing vaginal with cesarean section: vaginal accounted for 55% growth,
with 21% in cesarean.
Discussion (Implication to Practice)
Interprofessional teams are needed to address multidimensional aspects of care. New
protocols for suction equipment use will be essential based upon initial evidence of bacterial
microbes living within the BBSs. Furthermore, additional studies are needed to determine
efficacy of cleaning methods used in the hospital and home environments with regards to the
BBS. Through interdisciplinary partnerships, great strides will continue to ensure positive
outcomes for infants, minimizing illnesses and reducing healthcare costs for the pediatric
population.
Keywords
Blue-bulb syringe, newborn suctioning, oronasopharyngeal secretions, bacterial growth
in suctioning devices, airway clearance
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Introduction
One in seven infant deaths are caused by bacterial, viral, or fungal infections (Williams et
al., 2013). Systemic infections, such as bacterial pneumonia, cardiovascular disease, and acute
otitis media have a potential etiology in the oropharynx (Ullman, Long, & Lewis, 2011; Hilty et
al., 2012). The oral cavity contains a population of microorganisms (microflora) that is complex
and diverse, with influences such as health status, diet, age, and even geographic location
effecting individual colonies. External migration of these organisms may be precipitated through
avenues such as airborne droplets, secretions, intubation, and the insertion of suction devices;
therefore, medical professionals and parents must be cognizant of the potential harboring of
microscopic organisms on or within a number of surfaces, including medical instruments (Barfod
et al., 2011; Nayak, Kumar, Bhaskaranand, & Nayak, 2011).
One particular vehicle for potential migration of oral and nasal microorganisms is the
blue-bulb syringe (BBS). As a standard of practice during delivery of a neonate, the mouth and
nose are suctioned to remove amniotic fluid, maternal blood, and mucosal secretions. The BBS is
commonly employed as the device of choice for clearing these fluids (Gungor et al., 2005;
Waltman, Brewer, Rogers, & May, 2004). Although the cleaning procedures between usage
varies from hospital to hospital, the BBS may be reused a number of times to clear secretions
during the first moments after birth, up to discharge of mother and baby from the hospital. The
BBS may then be sent home with the infant to be stored, used, and cleaned by the infant’s
caregiver; however, the cleaning method is unclear and, once removed from a controlled
environment, such as a hospital, the variable of use is unknown. For instance, in a household
with multiple children, with various degrees of health histories, a BBS could plausibly be shared
among siblings or unrelated infants in diverse settings. Ghosh (2013) noted that some strains of

BACTERIAL COLONIES WITHIN A BLUE-BULB SYRINGE

6

microbes, though harmless in one host, might very well be pathogenic if introduced into another.
Innocuous microbes can become virulent intruders if contact occurs in someone not capable of
mounting a defense (e.g., the immunosuppressed patient). The enclosed environment within the
BBS has the potential of housing microbes (allowing for colonies to incubate) with the
possibility of microevolution occurring, creating a source of pathogens ready to be introduced
into an unsuspecting host.
Microevolution is a realistic concern when considering the reproduction (generation time)
of microbes is measured in minutes, not years. For instance, Staphylococcus aureus, a bacterium
commonly found in the respiratory tract, has a generation time of 20 to 30 minutes, with each
fission cycle providing an opportunity to acquire a virulent trait, or shed a trait, generating a new
pathogenic strain (Ghosh, 2013; Maurelli, 2006; Maurelli, Fernández, Bloch, Rode, & Fassano,
1998). Maurelli et al. (1998) suggests that Shigella spp. (a pathogen that causes dysentery)
evolved from E. coli, which is commensal (one species benefits without harming the other) to the
human intestine. Therefore, given the right environment, surrounded by a host of varying and
competing colonies of microbes, the BBS sitting within one’s medicine cabinet, or hidden away
in the bottom of a diaper bag, may be housing the next super infection. What seems to be an
innocent attempt to care for an infant’s congested nasal passage might actually be the act of
inoculating the child with a lethal pathogen unaware.
The aim of this descriptive pilot study is to test specimens harvested from BBSs to
determine if bacterial microbes migrated into the BBS following standard suctioning protocols in
three settings: 1) vaginal births, 2) cesarean births, and 3) a mother/baby unit upon discharge of
patient.
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Theoretical Framework
A single, planktonic (free-floating) organism, once identified through a culture and
sensitivity test, is generally treatable with an antibiotic. In contrast, a structured community of
invading sessile cells (attached to one another on a substrate) presents a greater challenge for the
medical professional to treat successfully. This community of organisms is known as a biofilm
(Alhede & Alhede, 2014). Alhede and Alhede (2014) noted that difficulties with treating
illnesses resulting from biofilms are due to the tolerance to antibiotics. Required treatments are
typically very high dosages nearing 1000 times the minimum concentrations. Illnesses of this
type are generally chronic due to the nature of the resisting biofilm to the host’s natural defenses.
Simply put, organisms have evolved; realizing there is strength, not only in numbers, but also in
variations of species making up their impenetrable community.
The biofilm theory states that bacterial organisms, when engaged in a community
consisting of layers of other organisms, attached to a substrate (e.g. medical device), will act and
react in a manner unlike the original organism in its single form (Romero et al., 2008). Romero
et al. (2008) noted, in a study of intraamniotic infections, that bacteria in biofilm communities
become more resistant to antimicrobial treatments. Furthermore, these communities of
microorganisms tend to camouflage infections, making isolation of individual organisms in a
culture very difficult. Infections in the amniotic fluid can have an etiology from biofilms. These
biofilms were able to form, as well as thrive, within a healthy uterus in the second trimester of
pregnancy. However, further studies must be conducted to determine the specific organisms
involved, as well as the potential detachment of biofilms due to fetal movement within the uterus
(Romero et al., 2008).
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Biofilms have been found colonizing medical devices such as catheters, pacemakers,
artificial joints, and breast implants (Romero et al., 2008). For the purpose of this study,
postulations are made that biofilms may also colonize within the BBS used for neonates and
infants. As noted earlier, biofilms are extremely resistant; therefore, traditional attempts to clean
a BBS using household agents may indeed be insufficient. For instance, the traditional BBS is a
one-piece design, with no option to access the interior surfaces to use mechanical friction (i.e. the
use of a brush) for cleaning without destroying the unit. Inaccessible surfaces, such as these, are
potential breeding grounds for microorganisms, allowing for unrestricted and undisturbed
growth. This hazardous condition may very well be the etiology of many childhood diseases;
therefore, additional studies are needed to identify specific microorganisms colonizing the
interior surfaces of the BBS. The act of squeezing the BBS may be the needed influence required
for a biofilm, or pathogenic microbe, to be released into the nasal or oral cavity of an infant.
Therefore, this study’s findings are crucial in determining whether microbes have indeed
migrated into the BBS, and if these microbes remain viable long enough to grow within a
microbiology lab setting.
Review of Literature
The following research studies were located using CINAHL. Criteria for the search
included: neonate microflora, oropharyngeal pathogens, microbial biofilm, and
oronasopharyngeal suctioning. Exclusions included: existing pathological illnesses, adult oral
health, and oral surgery. Other than an original study conducted by Maurelli et al. (1998)
concerning genetics of evolution, the literature review was limited to the past eleven years, peerreviewed, and when applicable, translated into English. No less than fifty articles were reviewed
during this study.
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A study conducted in Australia, by Ullman, Long, and Lewis (2011) explored the
relationship between oral dysfunction and healthcare-associated infections (HAI) or nosocomial
infections of patients admitted to the Pediatric Intensive Care Unit (PICU). The study, which was
conducted over a seven-month period, included 46 patients ranging from one month of age to
fourteen-years old whose admission into the PICU was ≥ 48 hours. The premise of the research
was to determine if critically ill pediatric patients would develop systemic infections while in the
PICU due to poor oral care. Ullman et al. (2011) noted that oral cavity microorganisms that are
typically commensal to the host have the ability to progress into a systemic illness due to poor
hygiene during hospitalization. The variability in standards of oral care by the nursing staff was
concerning. In fact, no standard existed for maintaining oral hygiene for these young patients,
making obvious observations that additional research should follow to produce evidence-based
practice in oral hygiene care for pediatric patients.
The study used the Oral Assessment Scale (OAS) for grading the oral health of each
participant. In addition to the OAS, samples of oropharyngeal saliva were collected within the
first 12 hours of admission, and then every 48 hours thereafter until discharge. The nurse used a
TRANSWAB® for collection by placing the swab into the patient’s mouth for a minimum of 30
seconds. The swabs were then sent to a lab for analysis. One hundred and fifty-two swabs were
collected during the seven-month study. Candida spp. was the most common colony found in the
oropharyngeal cavity, along with Staphylococcus aureus. These organisms cause systemic
illnesses, such as pneumonia and bloodstream infections. Other organisms inhabiting the
oropharyngeal cavity of the participants were H. influenzae, Enteroccus sp. and P. aeruginosa.
The oropharynx is home to a diverse environment of organisms. In their study, Nayak et
al. (2011) examined non-pathogenic microflora (NPM) and pathogenic microflora (PM) residing
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in the oral cavity of infants. They also examined factors that affected colonization of these
microflora. The subjects were 464 infants ranging in age from fifteen days old to one year old.
The study was conducted over a fourteen-month period, and included symptomatic and
asymptomatic infants. The only qualifying infection allowed in the study was upper respiratory
tract infection (URTI). The infants were divided into two groups: exclusively breast fed (EBF)
and mixed fed (MF); infants that were strictly formula fed were not enrolled in the study. Other
variables assessed included: seasons of the year and if the infant had a sibling living in the same
household. Oral specimens were obtained using two sterile cotton-tipped applicator sticks in an
aseptic manner on all subjects. Specimens were then analyzed using blood and chocolate agar
plates.
The results of this study revealed that infants older than six months of age were at high
risk for pathogenic colonization of bacteria within the oral cavity. Exclusively breast fed children
had more NPM, where the MF children had more PM colonizing within the oropharynx. There
was no significance in the number of family members living with the infant; PM did not
increase. However, seasonal influences were significant. As a result of this study, data suggests
that weaning an infant from breast milk does increase colonization of pathogenic bacteria in the
oropharynx.
Due to the potential biofilm that may colonize the interior surfaces of the BBS, one must
take into account the genetic influences placed upon this microscopic environment. A research
conducted by Maurelli et al. (1998) discusses the potential pathways for evolution in
microorganisms. The consideration of evolving microorganisms is especially critical when
evaluating the interior surfaces of the BBS with no clear solution for removing potential
biofilms. In addition, Ghosh (2013) examined the addition and deletion of genes during
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evolution. Maurelli et al. (1998) noted that evolutionary pathways to virulence in pathogens are
the deletion of genes, creating so-called black holes. Not only were the deletion of genes
indicated, but the study also noted pathogenicity islands (PAIs), which are regions on the
genome that contain large blocks of virulent genes. The following inference was made: when
commonly inheritable genes (that typically prevent virulent traits) are deleted through the
process of evolution, then virulent producing genes may be acquired (Maurelli et al., 1998).
Ghosh (2013) noted in his review that virulence could be attained through the addition of genes,
as well as the deletion of genes, that would typically be detrimental to the microbe’s pathogenic
influences on the host. Both sources clearly noted that additional research is needed.
Though much has been elucidated through these studies, much more still remains to be
learned. For instance, Ghosh (2013) noted that certain triggers or selective pressures that cause
the loss or gain of virulent genes are still unknown; if one could determine this, much progress
could be made in the fight against chronic diseases. Questions still remain regarding the level at
which gene exchange occurs, and whether the host contributes to this microbial evolution (i.e.
immune defenses or immunocompromised hosts).
A study by Barford et al. (2011) was aimed at identifying and comparing the microflora
of infants based upon the route of delivery. Eighty-four infants ranging from 6 to 10 months of
age (42 vaginal births and 42 cesarean births) were recruited. Infants presenting with
symptomatic illnesses and those who were delivered prematurely (<32 weeks) were not chosen
for the investigation. Saliva was collected and analyzed using a checkerboard DNA-DNA
hybridization. The findings of this study suggest that the mode of delivery has a direct influence
on salivary microflora profiles in infants. A significantly higher prevalence of Streptococci spp.
and Lactobacilli spp., associated with oral health, was found in infants of vaginal births when
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compared to cesarean births. The initial microflora, found in the vaginal birth group, may defend
against infections much earlier than a neonate who did not pass through the vaginal canal.
A randomized controlled trial by Gungor et al. (2005) and Neumann, Mounsey, and Das
(2014) compared neonates who were suctioned immediately after birth with those who were not.
According to these studies, few have questioned the traditional protocol of suctioning a healthy
newborn, and whether this practice has a positive or negative influence on the first moments of
life. The subjects in the Gungor et al. (2005) study were selected using the following criteria:
mother’s first pregnancy, single fetus, no complications during the pregnancy, no fetal distress,
clear amniotic fluid, and cephalic presentation. A total of 140 newborns were selected and
randomly assigned to one of two groups (suction and no suction) with 70 in each group.
Computer-generated random numbers were used to determine assignments, which were sealed
until opened in the delivery room.
The suction group followed standard hospital protocol for delivery, while the no suction
group used only one intervention: wipe away any visible matter. Lab values pO2, pCO2, and pH
(via umbilical arterial samples), along with SaO2 and heart rate values (via neonatal saturation
sensor located on the middle finger of the right hand), were measured, timed, and compared.
Along with these measurements, an Apgar score was recorded at one minute and five minutes
post birth. The normal ranges for lab values are as follows: pH: 7.35-7.45, pO2: 50-70 mmHg,
pCO2: 35-45 mmHg, SaO2: >92%, and heart rate: 120-160 beats per minute. Apgar is an
assessment scale used by the Registered Nurse (RN) immediately after birth to measure the
neonate’s initial condition. Activity (muscle tone), Pulse, Grimace (reflex irritability),
Appearance (skin color), and Respiration are all measured and assigned a number value. The
total of these five values results in an Apgar score: Severely Depressed 0-3, Moderately
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Depressed 4-6, and Excellent Condition 7-10. The results of the study indicated that at 6 minutes
post birth the no suction group achieved a higher SaO2 level (92.06%) quicker than the group
that was suctioned (83.37%). Heart rate (127 versus 135), pH (7.336 versus 7.356), and pO2
(20.57 versus 20.91) values were lower in the no suction group; the mean pCO2 (39.94 versus
39.80) was higher in the no suction group. Apgar scores at one minute were the same for both
groups; however, at five minutes, all neonates in the no suction group received a score of 10.
Only 32 of the 70 in the suction group scored a 10 at five minutes.
Gungor et al. (2005) noted that newborns in the no suction group had significantly lower
heart rates when compared to the suction group. Also, no suctioning appears to be superior to the
traditional practice of suctioning, in terms of reaching a SaO2 level of 92% much sooner. In
addition, the data found that Apgar scores were positively affected by not suctioning at birth.
However, since all subjects remained within normal limits (measured values), clinical
importance could not be determined. Additional studies must be conducted prior to determining
whether a neonate should, or should not, be suctioned at birth.
Based upon the review of literature, data suggests that the microflora profile of the
neonate’s oronasopharynx may very well be the functional route to many childhood diseases
(Williams et al., 2013). In addition, the oral care provided to neonates and infants may contribute
greatly to the health and well being of the child (Ullman, Long, and Lewis, 2011). For decades,
the BBS has been an integral part of the labor and delivery unit for suctioning the
oronasopharynx of neonates at birth. Though past studies have addressed the custom of
suctioning oral and nasal secretions at birth, continued research should be conducted on the
efficacy of this practice (Waltman et al., 2004). Until then, BBSs should be considered a
potential vehicle for migration and induction of viable bacterial microbes when incorporated
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(and reused) in the care of neonates and infants. Over the course of this study, evidence will be
sought to support the hypothesis that viable microbes have the potential of migrating from host
into the BBS. For example, Streptococcus agalactiae, which causes Group B Streptococcal
septicemia (GBS), if present in the birthing-mother’s vaginal canal, has the potential of
migrating into the neonate’s mouth (during the birth process), and then be suctioned into the
BBS (Soukka, Rantakokko-Jalava, Vähäkuopus, & Ruuskanen, 2010). If not disposed of, or
properly cleaned, this BBS now contains a microorganism with the potential of spreading to
other hosts, or reintroduced back into the neonate at a later date.
Methods
Upon receiving research approval from both the Institutional Review Board (IRB) at The
University of Alabama in Huntsville, and the Institutional Review Committee (IRC) from
Huntsville Hospital, Huntsville Alabama (Appendices A and B), the collection phase
commenced. During two weeks in August 2014, at a large urban teaching hospital, 175 BBSs
were collected and transported to a microbiology lab. BBS’s were collected in three settings: 1)
vaginal births, 2) cesarean births, and 3) a mother/baby unit upon discharge of patient. Prior to
collection, the primary investigator provided education to the staff RNs on the collection
procedures, placed a dedicated collection bin (clearly marked with the study’s name) on the unit
floor, and provided pre-labeled clean biohazard bags: Vaginal Birth, C-Section Birth, and
Discharge (Figure 1). Prior to the initial use, all BBSs were new, and packaged within a sealed
container labeled as sterile (Figure 2).
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Figure 1. Pre-labeled Biohazard Bags provided by research team to hospital.

Figure 2. Blue-Bulb Syringe.
Vaginal birth BBSs were collected after the initial use at birth of the neonate.
Immediately at birth, the health care provider suctioned the mouth and nose of the neonate and
then handed the bulb to the assisting RN. The BBS then remained at the neonate’s side during
the initial newborn exam and stabilization of mother. This stabilization period varied
approximately one to two hours. At the time of transfer from labor and delivery to the
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mother/baby unit, the BBS was collected and placed into a biohazard bag, then deposited into the
specified holding bin.
Cesarean birth BBSs were collected after approximately 1 to 1.5 hours in the PostAnesthesia Care Unit (PACU). At time of birth in the operating room, the health care provider
suctioned the mouth and nose of the newborn, and then placed the BBS in the accompanying
bassinet. The neonate was then moved to the PACU, where the initial exam was conducted,
awaiting the mother to join. During the 1 to 1.5 hours recovering in the PACU, the mother and
baby interacted with skin-to-skin contact and the BBS was used when necessary during the
extent of this time. At the time of transfer from PACU to the mother/baby unit, the BBS was
collected and placed into a biohazard bag, then deposited into the specified holding bin.
Discharge BBSs were collected after approximately 72 hours post birth, at the time of
discharge from the hospital. The RN provided a new (sterile) BBS at the time of transfer from
delivery onto the mother/baby unit and was stored within the bassinet for PRN (as needed)
usage. This BBS was used either by the RN or the caregiver within the patient’s room. To be
noted, the discharge BBS was, at times, out of the RN’s control; usage, cleaning, and storage
during those moments cannot be substantiated. When the neonate was in the nursery, the BBS
remained in the bassinet and in the control of the RN.
Once a day, during the two-week period, the primary investigator collected all BBSs that
were deposited into the dedicated bin and transported to a microbiology laboratory. Once in the
lab, each BBS was visually inspected (while remaining sealed within the biohazard bag), labeled
with collection date, assigned a specific nomenclature, placed into a large bin, and subsequently
placed into a walk-in refrigerated room at 4ºC until later processed (Figure 3).
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Figure 3. BBSs Dated and Labeled in Laboratory.
Upon completion of the collection phase and over the next four months, 50 BBSs were
randomly selected from the 175 samples to be analyzed for the presence of bacterial colonies.
The number of BBSs tested is as follows: Vaginal Birth: 20, Cesarean Birth: 14, and Discharge:
16. In addition to the 50 samples, 5 unused BBSs (sealed within the manufacturer’s packaging)
were tested as a control to confirm sterility of the product. The following process was completed
on each sample to test for the presence of migrating bacteria within the BBS:
The BBS was removed from the biohazard bag and placed upright within a plastic beaker
for support. Using a Gilson Pipetman® P1000, 10ml of sterile Phosphate Buffered Solution
(PBS) was injected into the BBS to reconstitute any dried secretions within the bulb and/or dilute
secretions for easy removal (Figure 4). Once the PBS was injected into the BBS (with the open
tip occluded), manual agitation of the bulb proceeded for 45 seconds.
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Figure 4. BBS injected with 10ml of PBS.
The solution within the BBS was then injected into a sterile 15ml centrifuge tube (Fisherbrand®
Disposable Sterile Tube) and sealed with a cap. The solution was further mixed on a vortex for 1
minute using a Vortex-GenieTM spinner. Using a P1000 pipet, 1ml of the solution from the
centrifuge tube was placed and swirled onto a blood agar plate (Fisherbrand® Petri Dish, 100mm
x 15mm). The plate was then placed into an incubator for 24 hours at 37ºC. After 24 hours, the
plate was inspected for visual confirmation of bacterial colonies. Annotations were recorded as
growth (Figure 5) or no growth (Figure 6). The preceding process was repeated for all BBSs
examined in this study. To prevent cross-contamination, one BBS was examined at a time using
aseptic techniques.

BACTERIAL COLONIES WITHIN A BLUE-BULB SYRINGE

Figure 5. Blood Agar Plate – Growth.
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Figure 6. Blood Agar Plate – No Growth.
Results

Of the 175 BBSs collected, 82 were vaginal, 32 cesarean, and 61 were discharge. Of the
50 randomly selected, 20 were vaginal birth BBSs, 14 cesarean births, and 16 were discharge
BBSs. Among the 50 BBSs, 21 (42% of samples) were positive for bacterial growth, while 29
(58% of samples) did not contain growth. Forty-four percent of the samples that contained
bacterial colonies were from discharge BBSs, while 41% were from BBSs collected in labor and
delivery. A further breakdown of the samples from labor and delivery showed a 55% growth rate
in vaginal BBSs, and a 21% growth rate in cesarean BBSs (Figure 7). Of the 21 BBSs that
contained bacterial growth, seven BBSs contained multiple colony types; visually different
morphology. Of the seven BBSs with multiple bacteria, four were vaginal BBSs, one cesarean,
and two discharge BBSs. The five unused control BBSs were all negative for bacterial growth.
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Figure 7. Bacterial Growth Rates.
Discussion
This study, based upon a current literature review, is the first of its kind: analyzing the
presence of bacterial colonies within a BBS. According to past studies, bacterial infections
within the oral and nasal cavities may contribute to debilitating childhood diseases, up to and
including death (Williams et al., 2013). Specific pathogenic microbes, such as Group B
Streptococcus (GBS), and Escherichia coli have known to be present within the vaginal canal at
birth and can plausibly migrate into the BBS upon suctioning the newborn’s oronasopharyngeal.
Data contained within this study supports the hypothesis that microbes migrate from neonate to
bulb and remain viable; therefore, future research in this area might focus on identifying the
specific organism(s) within the BBS. This knowledge will help lead future protocols in the
proper usage, cleaning, and storage of the BBS within the clinical and home settings.
Additional data obtained in the study showed a significant higher rate of bacterial growth
in the vaginal BBS when compared to the BBS used in a cesarean birth. This supports prior
studies indicating the neonate comes into contact with mom’s microflora within the vaginal canal
during birth. Future observations may focus on relevant patient history prior to birth, with
comparison to specific species of bacteria found residing in the BBS. For example, if the neonate
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was delivered through a precipitous birth, and the mother was positive for GBS (with no time to
treat prophylactically with antibiotics prior to birth), was the newborn exposed and infected with
the pathogen? This information will lead to further refining of protocols concerning the BBS.
According to Neumann, Mounsey and Das (2014), along with Gungor et al. (2005), the
healthcare industry may reconsider the effectiveness of the BBS in a healthy birth, and revise
protocols omitting the use altogether. If not removing the BBS from practice, then limiting its
use, discovering practical and effective cleaning solutions, or disposing of the BBS immediately
after use. Infectious controls are a high priority within the clinical environment; however, current
practices with the samples collected for this study allows for the BBS to be used multiple times
and in some scenarios may even be used on more than the intended subject, incurring multiple
hosts, and multiple infections.
Thirty-three percent of the 21 BBSs that were positive for growth contained multiple
bacterial species (based upon visual differences in physical characteristics). This finding suggests
that once multiple species of viable bacteria migrate into the BBS, cleaning may become even
more difficult due to biofilm morphology. Biofilms require a scraping technique (e.g. abrasive
brush used in conjunction with a cleaning agent) to remove, and the current design prevents the
BBS from being cleaned in this manner. This data supports a disposable method may indeed be
the safest protocol until further studies in cleaning methods are conducted.
Limitations
Limitations to the study: Registered Nurses, following routine protocols, collected the
BBSs outside of the presence of the research staff; prevention of cross-contamination with other
objects aside from the neonate cannot be validated. The discharge BBSs, during standard
practices, were left with the caregiver, away from the nurse; therefore, a guarantee cannot be
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made that the BBS was used only in the manner expected: neonate suctioning. In addition, not all
BBSs collected from the mother/baby unit (discharge BBSs) were used by the nurse or caregiver.
Upon visual inspection, 7 of the 16 discharge BBSs examined were clean, without any residue
expected from a used BBS, and subsequently resulted in negative growth. This factor may give
false negatives, as the study did not give latitude to testing unused BBSs other than the five
controls. Therefore, plausibility must be given that used discharge BBSs may indeed have a
higher growth rate than the data suggests.
Implication for Practice
The blue-bulb syringe has been used by health care providers for decades, and has
become commonplace in hospitals and private homes alike. Evidence now supports the
migration and colonization of viable bacteria within the BBS; therefore, additional studies are
needed to identify individual species of bacterium, whether these species have pathogenic traits,
and if these bacteria are capable of being reintroduced back into a host upon subsequent usage.
Considerations should center on developing protocols for the use of the BBS throughout the
entire clinical setting, not simply the birthing process. A focused study on cleaning and storage
of the BBS may reveal additional contaminations, allowing for testing of cleaning solutions and
methods to reduce or eliminate microorganism colonizing the interior surfaces.
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